| the effects of berberine combined with metformin on metabolic abnormalities and ovulation in patients with polycystic ovary syndrome: a randomized controlled study | the effects of berberine combined with metformin on metabolic abnormalities and ovulation in patients with polycystic ovary syndrome: a randomized controlled study | ChiCTR2200062984 |
| Berberine Hyperglycemic Clamp | Effect of Berberine on Insulin Release at a High Blood Glucose Level in Normal Man | NCT03972215 |
| Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. | Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in People Living With HIV. | NCT04860063 |
| A double-blind randomized controlled clinical study of intervention treatment of berberine on clinical symptoms and intestinal flora in patients with depression | A double-blind randomized controlled clinical study of intervention treatment of berberine on clinical symptoms and intestinal flora in patients with depression | ChiCTR2200057169 |
| Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers | Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers | NCT05463003 |
| Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension | Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension | NCT04790942 |
| Study on the effect of berberine on the prevention of anastomotic scar formation after dacryocystorhinostomy | Study on the effect of berberine on the prevention of anastomotic scar formation after dacryocystorhinostomy | ChiCTR2100042026 |
| Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy | Efficacy and Safety of Berberine Hydrochloride, Amoxicillin and Rabeprazole Triple Therapy in the First Eradication of Helicobacter Pylori | NCT04697186 |
| Effects Of Berberine Plus Inulin On Diabetes Care in Elder Patients With LADA | Effects of Berberine Plus Inulin on Diabetes Care in Elder Patients With Latent Autoimmune Diabetes in Adults: A Randomized Controlled Trial | NCT04698330 |
| Effect of berberine on blood glucose and lipid regulation in type 2 diabetes mellitus patients | Effect of berberine on blood glucose and lipid regulation in type 2 diabetes mellitus patients | ChiCTR1900023238 |
| The effect of berberine on the symptoms of patients with schizophrenia | The effect of berberine alkaloid on positive and negative symptoms in patients with schizophrenia: a randomized placebo-controlled double-blind clinical trial | IRCT20190726044339N1 |
| Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis | Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis: a Prospective Cohort Study | NCT04543643 |
| The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 | The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 | NCT04479202 |
| Effect of berberine on COVID-19 | Clinical trial of berberine against COVID-19 | IRCT20081019001369N2 |
| The effect of berberine hydrochloride on apolipoprotein A1, serum inflammatory factors, carotid atherosclerosis and clinical prognosis of patients with stroke | The effect of berberine hydrochloride on carotid atherosclerosis, middle cerebral artery stenosis and homocysteine in patients with stroke | ChiCTR2000029838 |
| The effect of herbal toothpaste containing berberine and saponin on oral and dental health | Clinical trial comparing the effect of standard toothpaste and herbal toothpaste containing berberine and saponin on dental plaque, gingival inflammation, and salivary bacterial count | IRCT20170316033099N13 |
| Effect of Gamma-cyclodextrin on the Bioavailability of Berberine | A Phase I, Randomized, Crossover, Double-blind, Pharmacokinetic Study of Berberine Released From Cyclodextrin in Healthy Volunteers | NCT04918667 |
| The Effect of Combined Supplementation of Berberine and Fenugreek Seed Powder on Inflammatory Factors and Lipid and Glucose Profile in Patients with Type 2 Diabetes | Comparison of the combined efficacy of berberine and fenugreek in controlling blood glucose and lipid profile and inflammatory factors in type 2 diabetic patients | IRCT20191229045937N1 |
| Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD) | The Effect of Berberine on Lipid Profile, Liver Enzymes and Fasting Blood Glucose in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial | NCT04049396 |
| Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease | The Study of Berberine Affecting Metabolism, Inflammation Status, Endothelial Function and Thrombotic Events in Patients With Coronary Artery Disease by Remodeling Gut Microbiota | NCT04434365 |
| Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study | Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study | NCT03976336 |
| Effects of Berberine on Intestinal Microflora, Metabolites and Cardiovascular Function in People After High Choline Diet | Effects of Berberine on Intestinal Microflora, Metabolites and Cardiovascular Function in People After High Choline Diet | ChiCTR2100046956 |
| A single-center, prospective, randomized controlled clinical study of the short-term efficacy and safety of berberine combined with XELOX chemotherapy for advanced gastric cancer | A single-center, prospective, randomized controlled clinical study of the short-term efficacy and safety of berberine combined with XELOX chemotherapy for advanced gastric cancer | ChiCTR2200061347 |
| Pharmacological Profile of Different Berberine Formulations, and Effects on Blood Sugar Levels | Comparing the Pharmacological Profile of Different Berberine Formulations, and Their Effects on Blood Sugar Levels | NCT05370261 |
| Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL. | Effect of Probiotics or Berberine Supplementation on Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL - A Randomized Double- Blind Clinical Study. | NCT05523024 |
| Comparing the effects of Berberine, Curcumine and gonadotropin-releasing hormone agonist (GnRH) on uterine leiomyoma volume | Comparing the effects of Berberine, Curcumine and gonadotropin-releasing hormone agonist (GnRH) on uterine leiomyoma volume , a controlled, randomized clinical trials | IRCT20220201053908N1 |
| Efficacy and safety of berberine hydrochloride gargle in the treatment of oral candidiasis: a randomized controlled trial | A randomized controlled study of berberine hydrochloride gargle in the treatment of oral candidiasis: a randomized controlled trial | ChiCTR2100053862 |
| """The effect of herbal supplements on neurotransmitters in the formation of dementia""" | """Evaluation of the possible effect of berberine supplementation on changes in serum levels of glutamate-dopamin-serotonin and GABA neurotransmitters in dementia patients""" | IRCT20211012052739N1 |
| Treatment Benefits of Berberine Supplementation for Women With PCOS | Effect of Berberine Supplementation on Metabolic and Hormonal Features in Women With Polycystic Ovary Syndrome (PCOS) | NCT05480670 |
| Treatment of minimal hepatic encephalopathy with berberine and caffeic acid | Berberine and caffeic acid in the treatment of mild hepatic encephalopathy: a randomized open-labled parallel controlled prospective study | ChiCTR2100052806 |
| Berberine for the intestinal metaplasia after endoscopic therapy for early-stage gastric cancer | Exploratory randomized controlled trial to evaluate intestinal metaplasia improvement of gastric mucosa with berberine in patients after endoscopic therapy for early-stage gastric cancer | JPRN-jRCTs031210319 |
| Berberine and Altered Fasting Glucose | Effectiveness of the Assumption of a Berberine Phytosoma-based Supplement on the Hematic Values of Glucose in a Group of Patients With Altered Fasting Glucose | NCT05031715 |
| Evaluation of the curative effect of berberine on patients with irritable bowel syndrome complicated with depression | A multicenter randomized controlled single-blind clinical study of berberine on the clinical symptoms and intestinal flora of patients with irritable bowel syndrome complicated with depression | ChiCTR2100049397 |
| Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication | Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line Eradication | NCT05014334 |
| Bioavailability of Berberine and Dihydroberberine and Their Impact on Glycemia | Bioavailability of Berberine and Dihydroberberine and Their Impact on Glycemia | NCT05021341 |
| Berberine and Polycystic Ovary Syndrome | Berberine is an Effective Insulin Sensitizer and Improves Homeostasis of Metabolic and Hormonal Disorders in Women With Polycystic Ovary Syndrome: a Novel Treatment Strategy for PCOS | NCT04932070 |
| Cardiovascular Diseases and Diabetes Prevention Programme in Metabolic Syndrome (CDPP) | Efficacy and Safety of Berberine on Primary Prevention of Cardiovascular Diseases and Diabetes in Metabolic Syndrome: a Randomized, Controlled Trial | NCT05105321 |
| Berberine acts on the Molecular Mechanism of Insulin Resistance in the treatment of Polycystic Ovary Syndrome by Gut microbiota | Berberine acts on the Molecular Mechanism of Insulin Resistance in the treatment of Polycystic Ovary Syndrome by Gut microbiota | ChiCTR1900022444 |
| Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention | A Single-center, Randomized, Open-label, Controlled, Dose-escalating, Parallel-group Study to Assess the Anti-platelet Effect of Berberine in Patients Receiving Aspirin and Clopidogrel After Percutaneous Coronary Intervention | NCT03378934 |
| A Mechanistic Randomized Controlled Trial on the Cardiovascular Effect of Berberine | Effect of Berberine on Cardiovascular Disease Risk Factors: a Mechanistic Randomized Controlled Trial | NCT03770325 |
| Effect of Administration of the Combination Bezafibrate More Berberine on Lipid Profile in Patients With Dyslipidemia | Effect of Administration of the Combination Bezafibrate More Berberine on Lipid Profile in Patients With Mixed Dyslipidemia | NCT02548832 |
| Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission | Phase I Trial of Berberine in Subjects With Ulcerative Colitis | NCT02365480 |
| Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy | Helicobacter Pylori Eradication With Berberine Hydrochloride,Esomeprazole,Amoxicillin and Clarithromycin Versus Bismuth,Esomeprazole,Amoxicillin,and Clarithromycin: a Randomized,Open-label, Non-inferiority, Phase ? Trail | NCT02296021 |
| Study of Berberine Hydrochloride in Prevention of Colorectal Adenomas Recurrence | A Randomized, Placebo-controlled, Multicenter, Prospective Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas | NCT02226185 |
| Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment | Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment:an Open-label, Multicenter,Randomized, Prospective,Controlled Study | NCT02082756 |
| Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study | Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study | NCT02078167 |
| Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment | Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment:an Open-label, Multicenter,Randomized, Prospective,Controlled Study | NCT02084004 |
| Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research | Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research | ChiCTR-TRC-13003691 |
| Effect of Berberis root active component (Berberine) in patients with Type2 Diabetes. | The effect of Berberis root active component (Berberine) on blood sugar control in patients with Type2 Diabetes. | IRCT2013040712933N1 |
| Effect of berberine on diabetic retinopathy | Effect of berberine on diabetic retinopathy | ChiCTR-TRC-12002898 |
| The Therapeutic Effects of Statins and Berberine on the Hyperlipemia | The Therapeutic Effects of Combination of Statins With Berberine on the Patients With Hyperlipemia:a Single-center, Open Clinical Trial | NCT01697735 |
| The Efficacy of Berberine on Patients with Psoriasis | The Comparison of Efficacy of Berberine and Placebo on Skin Lesions of Psoriasis Patients | IRCT201201305069N6 |
| Effect of Berberine on Hormonal and Metabolic Features in Obese Women With Polycystic Ovary Syndrome (PCOS) | Effect of Berberine on Hormonal and Metabolic Features in Obese Women With PCOS | NCT01138930 |
| Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine | Letrozole and Berberine in Infertile PCOS Patients | NCT01116167 |
| Clinical evaluation of berberine therapy of acute coronary syndrome | CEBTACS | ChiCTR-TRC-10000868 |
| Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double blind randomised controlled trial | Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double blind randomised controlled trial | ChiCTR-TRC-09000376 |
| Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease | Role of Pioglitazone and Berberine in Treatment of Non-alcoholic Fatty Liver Disease(NAFLD) Patients With Impaired Glucose Regulation or Type 2 Diabetes Mellitus | NCT00633282 |
| Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia | The Efficacy and Safety of Berberine in the Treatment of Type 2 Diabetes With Dyslipidemia | NCT00462046 |
| Therapeutic Effects of Berberine in Patients With Type 2 Diabetes | Effects of Berberine on Improvement of Glucose and Lipid Metabolism in Patients With Type 2 Diabetes | NCT00425009 |
| Comparative BE Study of BioSNEDS in healthy subjects | AN OPEN LABEL,BALANCED, SINGLE-DOSE,MULTI-TREATMENT, TWO PERIOD,TWO-WAY CROSSOVER, COMPARATIVE ORAL BIOAVAILABILITY STUDY OF THYMOPRO 50 MG BIOSNEDS (0.001004 G THYMOQUINONE/ML), BERBERISOL 500 MG BIOSNEDS (0.010046 G BERBERINE HCL/ML),RESVERASOL 1000 MG BIOSNEDS (0.020048 G RESVERATROL/ML),BIOQUERCETIN 475 MG BIOSNEDS (0.010045 G QUERCETIN/ML) ANDBIOBUTYRIN 500 MG BIOSNEDS (0.010096 G TRIBUTYRIN/ML) MANUFACTURED BY VERDANT NATURE SP Z.O.O., WITH CONVENTIONAL RESVERATROL EXTRACT 1000 MG (2 X 500 MG CAPSULE) DISTRIBUTED BY BIOLAB, CONVENTIONAL QUERCETIN 475 MG CAPSULE DISTRIBUTED BY SWANSON HEALTH PRODUCTS, CONVENTIONAL TRIBUTYRIN 500 MG CAPSULE DISTRIBUTED BY DEVA NUTRITION, CONVENTIONAL THYMOQUINONE 50 MG CAPSULE DISTRIBUTED BY TRIQUETRA HEALTH AND CONVENTIONAL BERBERINE 500 MG CAPSULE DISTRIBUTED BY MEDFUTURE IN HEALTHY ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS - Nil | CTRI/2024/10/074604 |
| Combination of Curcumin and Berberine Therapy in the Treatment of Post Acute Diverticulitis (SUDD) | Combination of Curcumin and Berberine Therapy in the Treatment of Post Acute Diverticulitis (AD) Symptomatic Uncomplicated Diverticular Disease (SUDD) | NCT05596214 |
| Study on the effect of berberine hydrochloride in the treatment of familial patients with familial adenomatous polyposis | Randomized, double blind, placebo-controlled study of berberine hydrochloride in the treatment of familial adenomatous polyposis | ChiCTR-IOR-15007227 |
| Combination of Danazole With Berberine in the Treatment of ITP | Combination of Danazole With Berberine in the Treatment of ITP | NCT03909763 |
| Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy | Helicobacter Pylori Eradication With Berberine Hydrochloride, Lansoprazole, Amoxicillin and Bismuth Versus Clarithromycin Bismuth, Lansoprazole and Amoxicillin: A Randomized, Open-label, Non-inferiority, Phase ? Trial | NCT02633930 |
| Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes | Multicenter Randomized Controlled Study of Berberine for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Renal Insufficient | NCT02808351 |
| Berberine containing therapy for Helicobacter Pylori treatment among patients with previous failed eradication | Berberine containing therapy for Helicobacter Pylori treatment among patients with previous failed eradication - Berberine containing therapy for patients with previous failed helicobacter pylori eradication | JPRN-UMIN000034555 |
| Berberine containing therapy for initial Helicobacter Pylori eradication | Berberine containing therapy for initial Helicobacter Pylori eradication - Berberine containing therapy for Helicobacter Pylori | JPRN-UMIN000034554 |
| Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients | Comparison of the Efficacy and Safety of Berberine and Metformin for Schizophrenia Patients With Metabolic Syndrome | NCT03708549 |
| A Randomized Controlled Trial for Efficacy and Safety of berberine on vasculopathy in patients with NSTE-ACS after stenting | A Randomized Controlled Trial for Efficacy and Safety of berberine on vasculopathy in patients with NSTE-ACS after stenting | ChiCTR1800018742 |
| Berberine containing quadruple therapy for initial Helicobacter Pylori eradication | Berberine containing quadruple therapy for initial Helicobacter Pylori eradication - Berberine containing therapy for Helicobacter Pylori | JPRN-UMIN000033829 |
| Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy | Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy | NCT03609892 |
| Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia | Berberine Effects on Clinical Symptoms and Metabolic Disturbance as an Adjunctive Therapy in Patients With Schizophrenia: a Randomized Double-blind Placebo-controlled Study | NCT03548155 |
| The mechanism of berberine to regulate the PI3K-AKT signal pathway in PCOS-IR | The mechanism of berberine to regulate the PI3K-AKT signal pathway in PCOS-IR | ChiCTR1800015605 |
| Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation | An Open-label Phase II Trial of Gefitinib and Berberine in Patients With Advanced Non-small Cell Lung Cancer and Activating EGFR Mutations | NCT03486496 |
| The Absorption of Bioactive Berberine in Human | To Test the Efficacy of Novel Berberine Emulsification by TPGS or Quillaja Extract on the Absorption of Berberine Compared to Berberine Powder in Humans | NCT03438292 |
| Evaluation of the efficacy of Berberine instead of clarithromycin against Helicobacter pylori in children, in vitro and in vivo | Evaluation of the efficacy of Berberine instead of clarithromycin against Helicobacter pylori in children, in vitro and in vivo | ChiCTR-IOR-17013319 |
| Effectiveness and Safety of Berberine Hydrochloride and Bifidobacterium in People With Abnormal Glucose Level | Effectiveness and Safety of Berberine Hydrochloride and Bifidobacterium in People With Abnormal Glucose Level: an Multicenter, Randomized, Double-blinded, Placebo-controlled Study. | NCT03330184 |
| The effect of berberine hydrochloride on the treatment of dyslipidemia with atherosclerosis | The effect of berberine hydrochloride on the treatment of dyslipidemia with atherosclerosis | ChiCTR-OPN-17012942 |
| Berberine Treat Metabolic Syndrome in Schizophrenia | Berberine in the Treatment of Metabolic Syndrome : an Open Label Clinical Study in Female Schizophrenia Patients | NCT03251716 |
| Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis | Efficacy and Safety of Berberine in Non-alcoholic Steatohepatitis: a Multicentre, Randomised, Placebo-controlled Trial | NCT03198572 |
| Berberine treat different curative effect observation of TCM syndrome type 2 diabetes | Berberine treat different curative effect observation of TCM syndrome type 2 diabetes | ChiCTR-INR-16009989 |
| Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes | Effect of Administration of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Patients With Prediabetes | NCT03029390 |
| Berberine as Adjuvant Treatment for Schizophrenia Patients | A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders | NCT02983188 |
| Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis | Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis: An Open-label,Randomized,Phase IV Clinical Trial | NCT02962245 |
| Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients | | NCT02936414 |
| A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes | Probiotics and BeRberine on the Efficacy and Change of Gut MicrObiota in paTients With Newly Diagnosed Type 2 diabEtes(PREMOTE Study) | NCT02861261 |
| The Therapeutic Effects of Insulin and Berberine on Stress Hyperglycemia | The Therapeutic Effects of Combination of Insulin With Berberine on the Patients With Stess Hyperlipemia:a Prospective, Double Blind, Randomized, Placebo-controlled, Single-center Clinical Trial | NCT02806999 |
| Berberine and Cinnamon in Management of Diabetes | The Effects of Berberine and Cinnamon Supplementation on Diabetes Mangement | NCT05570357 |
| Effect of Berberine mouthwash on pain caused by orthodontic treatments | Effect of Berberine mouthwash on pain caused by elastomeric Seprator placement | IRCT20181115041667N1 |
| A prospective, single-center, randomized controlled study of the efficacy of oral berberine hydrochloride in the treatment of diabetic nephropathy | Curative effect of berberine hydrochloride on diabetic nephropathy | ChiCTR2400083889 |
| Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine | Assessing the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine Using Randomized, Placebo-controlled, Double-masked Trial | NCT06782646 |
| Comparison of Metformin and Berberine in PCOD patients | Effects of Lifestyle Modification with Myoinositol and Berberine versus Myoinositol and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomized Study: A case report - NIL | CTRI/2025/04/085859 |
| Clinical study of Berberine extract in type 2 diabetes mellitus. | A randomized, double-blind, parallel-arm clinical trial to assess the efficacy and safety of Berberine extract in participants with type 2 diabetes mellitus. - NIL | CTRI/2024/12/078418 |
| Safety Profile of a New Berberine Formulation with Improved Bioavailability | Evaluating the Safety and Tolerability of LipoMicel Berberine | NCT06732908 |
| Effects of an herbal mixture plus D-mannose on the prevention of recurrent uncomplicated cystitis | Study on the effectiveness of an innovative combination of plant extracts (Berberine, Arbutin, Birch) that administered in conjunction with the D-mannose, for the prevention of recurrent urinary tract infections | ISRCTN13017713 |
| Gene Modulation of NLRP3, IL-1ß and TNF-a in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine | Gene Modulation of NLRP3, IL-1ß and TNF-a in Peripheral Blood of Patients With Exogenous Obesity Treated With Berberine | NCT06703086 |
| Bioavailability study on Healthy Subjects | A Randomized, double-blind, two arm, crossover design to assess the bioavailability of Liposomal berberine and berberine formulations in otherwise healthy volunteers - NIL | CTRI/2024/11/076293 |
| 6-year Follow-up Data After the Berberine Intervention Trial | A Multicenter, Placebo-controlled Clinical Study of Berberine Hydrochloride in Preventing Recurrence and Carcinogenesis After Endoscopic Removal of Colorectal Adenomas:6-year Retrospective Follow-up Data | NCT06629051 |
| Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori. | Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori. | NCT06603688 |
| A Single Dose Two-Way Crossover Oral Bioavailability Study Of The Study Product (BerbiQ) Which Contains Berberine, In Healthy, Adult, Human Subjects Under Fasting Conditions. | A Double-Blind, Randomized, Single Dose, Two-Treatment, Two-Way Crossover,Oral Bioavailability Study of Investigational Product (Berbiq) Containing Berberine, In Healthy,Adult, Human Subjects Under Fasting Conditions. - NIL | CTRI/2024/07/070781 |
| Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication | Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line Eradication | NCT06514274 |
| A bioavailability study to compare two Berberine formulations with two Berberine + Turmeric formulations in healthy adult human subjects. | Single dose, crossover bioavailability study to compare the Formulation A Berberine 95 percent with Formulation B Berberine 95 percent plus Turmeric and Formulation C Berberine 70 percent with Formulation D Berberine 70 percent plus Turmeric in healthy adult human subjects. - NIL | CTRI/2024/06/069426 |
| Gymnema Sylvestre vs Berberine in Obesity Gene Expression of Adipokines | Comparative Efficacy of Gymnema Sylvestre vs Berberine in the Clinical Outcomes and Gene Expression of Adipokines in Patients With Exogenous Obesity | NCT06426966 |
| A Pilot Study of Berberine (Soloways ™) in Patients with Type 2 Diabetes Mellitus Carrying TCF7L2 Polymorphisms | A Pilot Study of Berberine (Soloways ™) in Patients with Type 2 Diabetes Mellitus Carrying TCF7L2 Polymorphisms | NCT06863922 |
| Comparative Efficacy of Metformin and Berberine Among TCF7L2 (rs7903146) TT vs. CC Genotype Carriers With Type 2 Diabetes | Comparative Efficacy of Metformin and Berberine Among TCF7L2 (rs7903146) TT vs. CC Genotype Carriers With Type 2 Diabetes: A Pilot Randomized Clinical Study | NCT06911983 |
| Berberine extract in the management of type 2 diabetes mellitus | A randomized, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of standardized extract of berberine in patients with type 2 diabetes mellitus (T2DM). - NIL | CTRI/2024/04/065936 |
| Clinical study of berberine in the treatment of sepsis with acute gastrointestinal injury | Clinical study of berberine in the treatment of sepsis with acute gastrointestinal injury | ChiCTR2400082935 |
| Clinical Study With Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol | Clinical Study With Berberine-based Food Supplement, Artichoke Extract, Phytosterols, Fenugreek and SelectSIEVE® OptiChol | NCT06340308 |
| Effect of Oral Combined Berberine and Curcumin Pharmacological Therapy on IBS | The Adjuvant Synergistic Therapeutic Effect of Oral Berberine and Curcumin Alleviates Symptoms of Irritable Bowel Syndrome: Results From a Real-life Setting Clinical Intervention Study | NCT06187298 |
| Prevention and treatment of chemotherapy-induced diarrhea with berberine in colorectal cancer patients: a randomized, double-blind controlled study | Prevention and treatment of chemotherapy-induced diarrhea with berberine in colorectal cancer patients: a randomized, double-blind controlled study | ChiCTR2300078353 |
| Evaluation of the efficacy of berberine combined with Vonoprazan and amoxicillin for eradication of Helicobacter pylori | Evaluation of the efficacy of berberine combined with Vonoprazan and amoxicillin for eradication of Helicobacter pylori | ChiCTR2300077074 |
| Berberine on the Secretion of Incretin | The Effect of Berberine on the Secretion of Incretin in Normal Man | NCT05947370 |
| A Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects. | A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Effects of Akkermansia Muciniphila and Berberine on Prediabetes Among Obese Subjects. | NCT05720299 |
| Sex Differences in Berberine Pharmacokinetics | Sex Differences in Berberine Pharmacokinetics in Healthy Volunteers - BERKI-2 | NCT05845931 |
| The effect of quercetin and berberine on pulmonary arterial hypertension | Investigation of the effect of quercetin and berberine on laboratory and functional indices of the heart and pulmonary vessels in patients with pulmonary arterial hypertension | IRCT20230220057462N1 |
| Clinical study of combined application of Berberine hydrochloride tablets in the treatment of cholestatic liver disease | Clinical study of combined application of Berberine hydrochloride tablets in the treatment of cholestatic liver disease | ChiCTR2300068536 |
| Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus | Assess the Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus Among Individuals With High Cardiometabolic Risk | NCT05749874 |
| Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD | Assess the Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and Non-alcoholic Fatty Liver Disease | NCT05647915 |
